Blogs

With the impending expansion of the EU and the revamping of current policies, the pharmaceutical industry is on edge, wanting to know what the future holds.

To help protect patient safety and cut red tape, the European Union is working to create tougher standards of pharmacovigilance.

European Parliament debates on the allocation of research funds reveals Euro-MPs views of clinical research in medicines development.

A high-level group explores ways to support EU pharmaceutical industry research without too much cost to the EU health agencies that pay for medicines.

The EU?s Committee for Proprietary Medicinal Products describes the process clinical investigations should follow.

Patients, research companies, and regulatory authorities may all benefit from proposed changes to current pharmaceutical legislation, but the proposals will provoke much debate.

The EMEA updates its positions on placebos, Crohn?s disease trials, and postmarketing surveillance of drugs used by pregnant women.